article thumbnail

Wellness in 2023 Is About Connections, Mental Health and Science – Global Wellness Summit’s 2023 Trends

Health Populi

Beth McGroarty speaks eloquently about the loneliness epidemic, which continues to plague some of us in different ways: still viscerally remembering or being conscious of physical distancing, for example, or avoiding going to the gym continuing our online fitness gatherings.

article thumbnail

Shelly Palmer De-Hypes CES 2019 & Has Lessons for Health/Care

Health Populi

As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. But it’s not necessarily useful for everything.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BlackBerry Brings its EoT Vision to Healthcare to Improve Patient Outcomes

Lloyd Price

For example, data could be inputted by patients, laboratories, and IoT biometric devices, and then anonymized so this data can be shared with researchers.

BioTech 56
article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Evolution and Benefits of DHTs in Neurology Trials DHTs – like wearables, mobile health apps, and telemedicine platforms – have for example significantly impacted the design and execution of neurology trials. Another example is CliniScout Recruit by Healthware – a digital service for recruiting subjects to clinical trials.

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.